H Kanamaru

644 total citations
35 papers, 518 citations indexed

About

H Kanamaru is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, H Kanamaru has authored 35 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 14 papers in Surgery and 8 papers in Oncology. Recurrent topics in H Kanamaru's work include Bladder and Urothelial Cancer Treatments (5 papers), Multiple and Secondary Primary Cancers (4 papers) and Prostate Cancer Treatment and Research (4 papers). H Kanamaru is often cited by papers focused on Bladder and Urothelial Cancer Treatments (5 papers), Multiple and Secondary Primary Cancers (4 papers) and Prostate Cancer Treatment and Research (4 papers). H Kanamaru collaborates with scholars based in Japan and Pakistan. H Kanamaru's co-authors include Hironobu Akino, Nobuyuki Oyama, Yoshiharu Yonekura, Norihiro Sadato, O Yoshida, K Okada, Koichi Okada, Yuichiro Suzuki, Michael M. Gottesman and Shigetada Nakanishi and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, British Journal of Cancer and Heart.

In The Last Decade

H Kanamaru

33 papers receiving 500 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H Kanamaru Japan 12 239 146 142 135 120 35 518
Yoshimi Otani Japan 11 281 1.2× 153 1.0× 56 0.4× 168 1.2× 110 0.9× 38 574
Douglas Martin United States 15 223 0.9× 122 0.8× 249 1.8× 79 0.6× 129 1.1× 41 702
Naoki Ishiwa Japan 11 173 0.7× 152 1.0× 53 0.4× 108 0.8× 125 1.0× 27 424
Phillips Tl United States 12 143 0.6× 96 0.7× 136 1.0× 68 0.5× 67 0.6× 22 466
Isao Asakawa Japan 15 399 1.7× 86 0.6× 139 1.0× 98 0.7× 69 0.6× 60 575
Li Yan Khor Singapore 11 272 1.1× 114 0.8× 47 0.3× 173 1.3× 91 0.8× 36 470
Kiyohiko Dohi Japan 14 257 1.1× 168 1.2× 46 0.3× 183 1.4× 195 1.6× 43 751
Peggy S. Esper United States 11 319 1.3× 167 1.1× 27 0.2× 101 0.7× 113 0.9× 16 521
Masayuki Iwazaki Japan 15 358 1.5× 199 1.4× 40 0.3× 156 1.2× 170 1.4× 92 718
Masatoshi Muramoto Japan 8 419 1.8× 80 0.5× 59 0.4× 120 0.9× 82 0.7× 15 558

Countries citing papers authored by H Kanamaru

Since Specialization
Citations

This map shows the geographic impact of H Kanamaru's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Kanamaru with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Kanamaru more than expected).

Fields of papers citing papers by H Kanamaru

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H Kanamaru. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Kanamaru. The network helps show where H Kanamaru may publish in the future.

Co-authorship network of co-authors of H Kanamaru

This figure shows the co-authorship network connecting the top 25 collaborators of H Kanamaru. A scholar is included among the top collaborators of H Kanamaru based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Kanamaru. H Kanamaru is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yoshida, Shigeo, et al.. (2016). Improved efficiency of asymmetric hydrolysis of 3-substituted glutaric acid diamides with an engineered amidase. Journal of Applied Microbiology. 120(6). 1542–1551. 6 indexed citations
2.
Yabuki, Masashi, et al.. (2005). Characterization of the enzymes involved in thein vitrometabolism of amrubicin hydrochloride. Xenobiotica. 35(12). 1121–1133. 27 indexed citations
3.
Shimakura, Jin, Keiichi Fujimoto, Setsuko Komuro, Minoru Nakano, & H Kanamaru. (2002). Long-term disposition of a novel lipophilic platinum complex SM-11355 in dog after intrahepatic arterial administration: highly sensitive detection of platinum and radioactivity. Xenobiotica. 32(5). 399–409. 9 indexed citations
4.
Noto, Nobutaka, Kensuke Karasawa, H Kanamaru, et al.. (2002). Non-invasive measurement of coronary flow reserve in children with Kawasaki disease. Heart. 87(6). 559–565. 20 indexed citations
5.
Oyama, Nobuyuki, Hironobu Akino, Yuji Suzuki, et al.. (2001). FDG PET for evaluating the change of glucose metabolism in prostate cancer after androgen ablation. Nuclear Medicine Communications. 22(9). 963–969. 88 indexed citations
6.
Kanamaru, H, Masaki Kakeyama, Tatsunori Seki, & Yasumasa Arai. (2001). Estrogen potentiates N-methyl-d-aspartate receptor subunit R2B mRNA expression during the late prepubertal period in female rats. Neuroscience Letters. 300(1). 9–12. 8 indexed citations
7.
Kanamaru, H, Nobuyuki Oyama, Hironobu Akino, & K Okada. (2000). [Evaluation of prostate cancer using FDG-PET].. PubMed. 46(11). 851–3. 16 indexed citations
8.
9.
Kanamaru, H, Yoichi Arai, Hironobu Akino, et al.. (1999). Long Term Treatment Results of Elderly Patients with Prostate Cancer in Japan: an Analysis of Prognostic Factors. Japanese Journal of Clinical Oncology. 29(3). 151–155. 4 indexed citations
10.
Oyama, Nobuyuki, Hironobu Akino, Yuichiro Suzuki, et al.. (1999). The Increased Accumulation of [18F]Fluorodeoxyglucose in Untreated Prostate Cancer. Japanese Journal of Clinical Oncology. 29(12). 623–629. 118 indexed citations
11.
Mori, Hirotaka, et al.. (1998). Expression of c-MET/HGF receptor mRNA and protein in human non-malignant and malignant prostate tissues.. International Journal of Oncology. 13(5). 927–34. 15 indexed citations
12.
Aoki, Y., Yoshiji Miwa, Yasutomo Suzuki, et al.. (1998). [A collision tumor between squamous cell carcinoma and malignant lymphoma of urinary bladder: a case report].. PubMed. 44(3). 179–82. 5 indexed citations
13.
Mori, Hirotaka, et al.. (1998). Enhanced hepatocyte growth factor level in human prostate cancer treated with endocrine therapy.. PubMed. 13(1). 169–76. 11 indexed citations
14.
Maruyama, Yasuhiko, et al.. (1997). A Case of Phlebosclerotic Ischemic Colitis: A Distinct Entity. Endoscopy. 29(4). 334–334. 12 indexed citations
15.
Yabuki, Masashi, et al.. (1997). Metabolism of 4-[1-(2-fluoro-4-biphenylyl)ethyl]-2-methylaminothiazole (SM-8849) in rats. European Journal of Drug Metabolism and Pharmacokinetics. 22(1). 25–33. 3 indexed citations
16.
Fujioka, Mutsuhisa, et al.. (1994). Two Cases of Adult Presacral Tumor.. Nihon Daicho Komonbyo Gakkai Zasshi. 47(1). 86–91. 1 indexed citations
17.
Nishio, Yasunori, H Kanamaru, Yasunobu Okada, et al.. (1991). Impaired interferon-? production in whole-blood cultures from bladder cancer patients. Urological Research. 19(1). 51–56. 8 indexed citations
18.
19.
Kanamaru, H, Yoshiyuki Kakehi, O Yoshida, et al.. (1989). MDR1 RNA Levels in Human Renal Cell Carcinomas: Correlation With Grade and Prediction of Reversal of Doxorubicin Resistance by Quinidine in Tumor Explants. JNCI Journal of the National Cancer Institute. 81(11). 844–849. 96 indexed citations
20.
Tanaka, M., et al.. (1989). In vitro antagonism between cisplatin and vinca alkaloids. British Journal of Cancer. 59(1). 36–41. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshimi Otani Breakdown of academic impact, for papers by Douglas Martin Breakdown of academic impact, for papers by Naoki Ishiwa Breakdown of academic impact, for papers by Phillips Tl Breakdown of academic impact, for papers by Isao Asakawa Breakdown of academic impact, for papers by Li Yan Khor Breakdown of academic impact, for papers by Kiyohiko Dohi Breakdown of academic impact, for papers by Peggy S. Esper Breakdown of academic impact, for papers by Masayuki Iwazaki Breakdown of academic impact, for papers by Masatoshi Muramoto
Rankless by CCL
2026